Purdue Pharma LP won court approval to exit bankruptcy, capping six years of legal wrangling over a multibillion-dollar settlement and liability releases for the opioid manufacturer’s Sackler family owners. Judge Sean H...
Pfizer completes up to $10 billion acquisition of Metsera
Pfizer on Thursday closed its up to $10 billion acquisition of Metsera after winning shareholder approval, gaining a foothold in the fast-growing obesity market following a fierce bidding war with Novo Nordisk. The...
Pfizer slashes stake in COVID vaccine partner BioNTech
Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both firms formed an alliance that yielded a vaccine to combat the deadly COVID-19 pandemic. The U.S...
Merck nearing deal for Cidara, FT reports
Merck is closing in on a deal to buy Cidara Therapeutics in a deal valuing the biotechnology company at a premium to its $3.3 billion market capitalization, the Financial Times reported on Thursday. The deal could be...
Shah Capital pushes for Novavax sale, warns of proxy fight
Shah Capital, Novavax’s second-largest shareholder, is pressing the biotech’s board to pursue strategic changes, including a potential sale, and warned it could launch a proxy fight if no progress is made in...
Pfizer to acquire obesity drug startup Metsera in $10 billion deal
Obesity drug developer Metsera said Friday that it had agreed to a deal to be acquired by Pfizer, which had been locked in a bidding war for the company with Novo Nordisk, the Danish maker of weight-loss treatments...
Metsera accepts Pfizer’s $10 billion bid in ongoing M&A battle
Obesity drug developer Metsera said on Friday that it accepted Pfizer’s $10 billion acquisition offer, in what could be the end of a bidding war between the New York-based pharma giant and rival Novo Nordisk that...
Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera
Pfizer and Novo Nordisk’s fight for obesity drug developer Metsera ratcheted up on Tuesday, as both companies submitted sweetened bids, with Metsera saying Novo’s $10 billion offer is superior. The dramatic...
Cipla to fully acquire Inzpera Healthscience
Drug maker Cipla on Monday said it has inked a pact to fully acquire Inzpera Healthscience for around Rs 111 crore. The drug maker has entered into definitive agreements to acquire 100 per cent stake in Inzpera...
Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up
Novo Nordisk and Pfizer have revised their bids for Metsera, the obesity drug developer said on Tuesday. Novo’s revised offer brings the deal value to about $10 billion, while Pfizer is now willing to shell out $8...
Novartis to acquire Avidity Biosciences for about $12 billion
Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in cash, as the company looks to bolster its portfolio of treatments for rare muscle disorders. As...
CCI clears Torrent Pharma’s proposal to buy stake in JB Chemicals
Fair trade regulator CCI on Tuesday cleared Torrent Pharmaceuticals Ltd’s proposed acquisition of a stake in JB Chemicals and Pharmaceuticals, subject to voluntary modifications offered by the companies. The...
